Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,162 | -16,953 | -12,127 | -8,295 | -3,984 |
| Depreciation Amortization | -80 | 213 | 136 | 101 | -30 |
| Accounts receivable | -52 | 95 | 13 | 43 | 123 |
| Accounts payable and accrued liabilities | -751 | 944 | -729 | 812 | 483 |
| Other Working Capital | -1,071 | 2,752 | 1,226 | 900 | 606 |
| Other Operating Activity | 1,242 | 820 | 2,176 | 346 | -278 |
| Operating Cash Flow | $-3,874 | $-12,129 | $-9,305 | $-6,093 | $-3,080 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,444 | 13,955 | 9,956 | 6,250 | 2,016 |
| PPE Investments | -7 | -4 | -26 | -23 | -8 |
| Purchase Of Investment | N/A | -7,615 | -2,480 | -1,212 | N/A |
| Investing Cash Flow | $2,437 | $6,336 | $7,450 | $5,015 | $2,008 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 4,734 | 4,734 | 11 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -143 | 0 |
| Financing Cash Flow | $N/A | $4,734 | $4,734 | $-132 | $N/A |
| Beginning Cash Position | 3,097 | 4,156 | 4,156 | 4,156 | 4,156 |
| End Cash Position | 1,660 | 3,097 | 7,035 | 2,946 | 3,084 |
| Net Cash Flow | $-1,437 | $-1,059 | $2,879 | $-1,210 | $-1,072 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,874 | -12,129 | -9,305 | -6,093 | -3,080 |
| Capital Expenditure | -7 | -17 | -26 | -23 | -8 |
| Free Cash Flow | -3,881 | -12,146 | -9,331 | -6,116 | -3,088 |